Renalytix Plc (RENX.L)
GBp 8.0
(0.0%)
GBp 8.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 11.05 Billion EUR | 31251.93% |
| 2022 | -35.49 Million USD | 21.31% |
| 2021 | -45.11 Million USD | -14.46% |
| 2020 | -39.41 Million USD | -332.28% |
| 2019 | -9.11 Million USD | -69.68% |
| 2018 | -5.37 Million USD | -100.04% |
| 2017 | 13.12 Billion EUR | 36.0% |
| 2016 | 9.65 Billion EUR | 1.41% |
| 2015 | 9.51 Billion EUR | -12.75% |
| 2014 | 10.9 Billion EUR | -7.18% |
| 2013 | 11.75 Billion EUR | 11.0% |
| 2012 | 10.58 Billion EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -7.64 Million USD | -7.53% |
| 2023 FY | - EUR | 31251.93% |
| 2023 Q1 | -7.1 Million USD | 15.31% |
| 2022 FY | - USD | 21.31% |
| 2022 Q3 | -9.87 Million USD | -13.09% |
| 2022 Q2 | -8.73 Million USD | 8.29% |
| 2022 Q1 | -9.52 Million USD | -1.85% |
| 2022 Q4 | -8.39 Million USD | 15.03% |
| 2021 Q2 | -12.26 Million USD | -10.58% |
| 2021 Q3 | -11.83 Million USD | 3.48% |
| 2021 Q4 | -9.35 Million USD | 20.97% |
| 2021 FY | - USD | -14.46% |
| 2021 Q1 | -11.08 Million USD | 8.75% |
| 2020 Q2 | -13.55 Million USD | -152.1% |
| 2020 FY | - USD | -332.28% |
| 2020 Q3 | -8.66 Million USD | 36.04% |
| 2020 Q1 | -5.37 Million USD | -172.75% |
| 2020 Q4 | -12.15 Million USD | -40.18% |
| 2019 Q1 | -2 Million USD | -100.06% |
| 2019 FY | - USD | -69.68% |
| 2019 Q4 | -1.97 Million USD | 26.48% |
| 2019 Q2 | -2.18 Million USD | -9.01% |
| 2019 Q3 | -2.68 Million USD | -22.48% |
| 2018 Q4 | 3.41 Billion EUR | 1.38% |
| 2018 Q3 | 3.36 Billion EUR | -2.65% |
| 2018 Q2 | 3.45 Billion EUR | 26.35% |
| 2018 Q1 | 2.73 Billion EUR | 3456864.02% |
| 2018 FY | - USD | -100.04% |
| 2017 Q3 | 3.67 Billion EUR | -2.37% |
| 2017 FY | - EUR | 36.0% |
| 2017 Q4 | -79.17 Thousand USD | -100.0% |
| 2017 Q2 | 3.76 Billion EUR | 46.8% |
| 2017 Q1 | 2.56 Billion EUR | -20.47% |
| 2016 FY | - EUR | 1.41% |
| 2016 Q4 | 3.22 Billion EUR | 7.06% |
| 2016 Q2 | 2.12 Billion EUR | -6.3% |
| 2016 Q1 | 2.26 Billion EUR | -15.61% |
| 2016 Q3 | 3 Billion EUR | 41.55% |
| 2015 Q4 | 2.68 Billion EUR | -2.49% |
| 2015 FY | - EUR | -12.75% |
| 2015 Q3 | 2.75 Billion EUR | 12.29% |
| 2015 Q2 | 2.45 Billion EUR | 10.24% |
| 2015 Q1 | 2.22 Billion EUR | -11.3% |
| 2014 Q4 | 2.51 Billion EUR | 3.69% |
| 2014 Q3 | 2.42 Billion EUR | -25.17% |
| 2014 FY | - EUR | -7.18% |
| 2014 Q1 | 3.14 Billion EUR | 19.7% |
| 2014 Q2 | 3.23 Billion EUR | 2.75% |
| 2013 Q4 | 2.63 Billion EUR | -0.64% |
| 2013 Q1 | 2.89 Billion EUR | 9.11% |
| 2013 Q3 | 2.64 Billion EUR | -16.57% |
| 2013 Q2 | 3.17 Billion EUR | 9.49% |
| 2013 FY | - EUR | 11.0% |
| 2012 Q3 | 2.61 Billion EUR | -6.13% |
| 2012 Q4 | 2.65 Billion EUR | 1.46% |
| 2012 FY | - EUR | 0.0% |
| 2012 Q1 | 2.49 Billion EUR | 0.0% |
| 2012 Q2 | 2.78 Billion EUR | 11.63% |
| Name | EBITDA | EBITDA Difference |
|---|